Self-controlled assessment of thromboembolic event (TEE) risk following intravenous immune globulin (IGIV) in the U.S. (2006-2012).
Ammann EM, Chrischilles EA, Carnahan RM, Fireman B, Fuller CC, Schweizer ML, Garcia C, Pimentel M, Leonard CE, Baker MA, Cuker A, Leira EC, Robinson JG, Winiecki SK.
Ammann EM, et al. Among authors: winiecki sk.
J Thromb Thrombolysis. 2022 Feb;53(2):264-272. doi: 10.1007/s11239-021-02610-4. Epub 2021 Nov 24.
J Thromb Thrombolysis. 2022.
PMID: 34817789